Twice-daily topical GHK-Cu was associated with improvements in laxity, clarity, firmness, fine lines, wrinkles, pigmentation, and density
Since both GLP-1 and GIP work together to encourage insulin secretion, tirzepatide can further improve a patients glycemic control
If you experience side effects like vomiting or constipation that lasts more than a few days, contact your doctor right away, Rhodes says
Keep up with new research to see how triple-agonist drugs could transform treatment for diabetes and obesity
Trigger satiety, optimise digestion, and reduce cravings with the concentrated power of GLP-1-activating drops For thousands of years, humans thrived on natural, whole foods including bitter plants that played a crucial role in appetite regulation and digestion
"LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial." The Lancet
.webp)
